Vaxtex Cotfab Limited — Results, 23-05-2025: Integrated Filing- Financial

Vaxtex Cotfab has announced a board meeting.

Revenue Performance: The company reported total revenue of ₹5.25 Cr for the quarter, marking a strong rebound from negative revenue a year ago. Annual revenue stood at ₹17.06 Cr, supported by its textile trading and manufacturing operations.

Profitability and EPS: Net profit rose sharply to ₹1.32 Cr for the quarter versus a loss previously, with EPS at ₹0.072. Full-year profit was ₹0.88 Cr compared to a substantial loss last year, driven by better operational efficiency and improved margins.

Operational Costs: Total quarterly expenses were ₹5.43 Cr, mainly due to purchases of stock-in-trade (₹5.05 Cr). Employee costs saw a minor uptick but remained low at ₹0.02 Cr. Finance costs increased to ₹0.06 Cr. Overall, cost control and margin improvement were evident despite some cost pressures.

Key Metrics: EBITDA and PAT have turned positive, signaling operational stabilization. Depreciation was stable, reflecting consistent asset utilization.

Balance Sheet / Cash Flow Health: Operating cash flow was healthy at ₹1.23 Cr. A significant ₹7.6 Cr outflow in financing activities indicates active debt repayment post-CIRP, highlighting the company’s focus on strengthening its financial position.

Management Commentary / Strategic Outlook: Post-CIRP, management appears stable with no clear announcements on expansion or capex yet. The improved profitability and cash flow create a base for future growth.

Final Takeaway: Vaxtex Cotfab shows encouraging signs of recovery with solid profitability and cash flow improvements. Retail investors should watch debt reduction progress and volume trends to assess sustained turnaround potential.